Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Secondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology
Fabian Szepanowski, Clemens Warnke, Gerd Meyer zu Hörste, et al.
CNS Drugs (2021) Vol. 35, Iss. 11, pp. 1173-1188
Open Access | Times Cited: 14

Showing 14 citing articles:

Antibiotic failure: Beyond antimicrobial resistance
César de la Fuente‐Núñez, Angela Cesaro, Robert E. W. Hancock
Drug Resistance Updates (2023) Vol. 71, pp. 101012-101012
Closed Access | Times Cited: 77
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Tania Kümpfel, Katrin Giglhuber, Orhan Aktaş, et al.
Journal of Neurology (2023) Vol. 271, Iss. 1, pp. 141-176
Open Access | Times Cited: 70
Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis
Océane Perdaens, Vincent Van Pesch
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 37
Clinical opinions and case studies on understanding and managing hypogammaglobulinaemia in multiple sclerosis: United Kingdom perspective
Sharmilee Gnanapavan, Angray S. Kang, David Baker, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 96, pp. 106353-106353
Open Access
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 675-675
Open Access | Times Cited: 1
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: a multicentre study
Krzysztof Smolik, Federico Camilli, Ivan Panzera, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 93, pp. 106191-106191
Open Access | Times Cited: 1
The effect of cladribine on immunoglobulin levels compared to B cell targeting therapies in multiple sclerosis
Mitchell J. Lycett, Rod A. Lea, Vicki E. Maltby, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method
Ralf Gold, Michael Barnett, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders (2023) Vol. 16
Open Access | Times Cited: 3
COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional Study
Venja Musche, Alexander Bäuerle, Lisa Maria Jahre, et al.
Neurology and Therapy (2022) Vol. 11, Iss. 3, pp. 1135-1146
Open Access | Times Cited: 5
An Overview of the Immune Response to COVID-19 Vaccination and Strategies to Boost SARS-CoV-2 Immunity in People with Inborn Errors of Immunity
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
(2024)
Open Access
Disseminated Ureaplasma Infection: A Case Report of Septic Polyarthritis in a Patient on Rituximab Therapy
Michael Axenhus, Jesper Ericson, Agata Rysinska, et al.
IDCases (2024) Vol. 38, pp. e02101-e02101
Open Access
Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis
Guanlian Hu, Xue Zhao, Yiren Wang, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 707-720
Open Access
Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?
Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4786-4786
Open Access
High-dose biotin neither fosters remyelination nor stimulates malonyl coenzyme A synthesis in the regenerating nerve
Fabian Szepanowski, Rebecca D. Steubing, Cansu Güngör, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 7, pp. 1623-1623
Open Access
Page 1

Scroll to top